30,000 people to enter final testing phase of COVID-19 vaccine


Share post:

An experimental vaccine developed by the National Institute of Health and Moderna Inc will start the final testing phase in the U.S. beginning with 30,000 people on July 27th.

The testing will be a key phase in the road to a vaccine against COVID-19.

“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert, told The Associated Press.

Fauci’s colleagues at the Institute are the developers behind the would be vaccine. The phase is being entered following a testing of 45 volunteers, who submitted to testing in March.  The goal of the vaccine is to offer an immune boost against the pandemic.

There are no guarantees to the virus, but it would require two doses, set two months apart to administer.

Side effects were reported with the drug with over half of participants reporting reactions uncommon to other vaccines, including fatigue, headache, chills, fever and pain at the injection site.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related articles

Mis-Dials Overwhelming Grundy County’s 911 Center: Stay Connected, Save a Life

GRUNDY COUNTY, Ill. - Summer is here, and with it comes a friendly reminder to be cautious with our...

Two Rescued After Drowning Incident in Illinois Neighborhood

WOODRIDGE, Ill. - In a swift response to a distress call reporting a drowning incident, two individuals were...

South Suburbs to See First Drone Light Show Later Tonight

FRANKFORT, IL - The south suburbs are set to witness their first-ever drone light show later tonight in Frankfort....

Unidentified Gunman Strikes Chicago’s Museum Campus: Leaves Man In Critical Condition

CHICAGO, IL - A man was critically wounded in a shooting incident that took place on Sunday morning at...